相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
30
- 英文名:
Thalidomide
- CAS号:
50-35-1
- 供应商:
上海莼试
- 保存条件:
Store at -20°C
- 规格:
10mM (in 1mL DMSO) 200mg
| 货号 | CS-01Y66434 | 规格 | 10mM (in 1mL DMSO) 200mg |
| CAS号 | 50-35-1 | 分子量 | 258.23 |
| 含量 | >98.00% | 别名 | |
| 分子式 | C13H10N2O4 | 化学名 | 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
| 产地 | 国产 | 用途 | 仅供科研研究实验 |
分子式:C13H10N2O4

分子量:258.23
溶解度:≥ 11.8 mg/mL in DMSO
储存条件:Store at -20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition:Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request
Thalidomide is initially promoted as a sedative, inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ~250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties.Thalidomide is initially promoted as a sedative, has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties, and targets cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ~250 nM[1]. Thalidomide (50 μg/mL) potentiates the anti-tumor activity of icotinib against the proliferation of both PC9 and A549 cells, and this effect is correlated with apoptosis and cell migration. In addition, Thalidomide and icotinib inhibits the EGFR and VEGF-R2 pathways in PC9 cells[3].Thalidomide (100 mg/kg, p.o.) inhibits the collagen deposition, down-regulates the mRNA expression level of α-SMA and collagen I, and significantly reduces the pro-inflammatory cytokines in RILF mice. Thalidomide alleviates RILF via suppression of ROS and down-regulation of TGF-β/Smad pathway dependent on Nrf2 status[2]. Thalidomide (200 mg/kg, p.o.) combined with icotinib shows synergistic anti-tumor effects in nude mice bearing PC9 cells, suppressing tumor growth and promoting tumor death[3].
注意事项:
抗逆滴加序列
每次向板内滴加抗原时,移液器滴头要与平面45度悬空,不要触碰到孔内的液体,由后向前依次滴加(即浓度由低往高滴加)。
抗感染反应期
抗原抗体在室温20~25℃下,必须反应30min以上,若环境温度低于室温,可将微量反应板置于恒温培养箱中,使二者充分反应。
旅游温度
磷酸盐缓冲液的pH值要在高压灭菌后进行滴定,往往在高压后pH值会有所改变,所以高压后再调一次pH值更为准确。磷酸盐缓冲液一经使用保存期不要超过3周。当pH<5.8时,红细胞会产生自凝现象;当pH>7.8时,图形洗脱加快,易造成肉眼观察产生误差;p H=7.2时,红细胞沉降最充分,图形最清晰。
当滴注 1%红细胞悬液时,应经常摇晃红细胞悬液,使红细胞均匀地分布在磷酸缓冲液中,以防止红细胞下降。
反应时间及温度
加入鸡红血球之后,反应板在室温(20~25℃)静置30~40min,对照孔血球下沉于孔底,即可判定结果。若室温达不到实验要求,需相应调整反应时间。当环境温度低于4℃时,红细胞发生自凝;高于37℃时,会发生反应物分离和红细胞溶血。
使用方法:
1.本蛋白酶抑制剂混合物为100×的储存液,使用时按照1:100的比例加入到裂解液中(例如,1ml裂解液中加入10μl蛋白酶抑制剂混合物),混匀后即可使用。根据需要,0.5M的EDTA也按照1:100的比例加入到裂解液中(如用于检测金属蛋白酶活性,则不宜添加EDTA)。含有蛋白酶抑制剂混合物的裂解液宜现用现配,不宜配制后冻存待后续使用。
2. 待所需的抑制剂添加完毕混匀后,就可以开始进行哺乳动物组织的裂解和蛋白提取。
公司正在出售的产品:
| Recombnant Human MARCO, N-H | LDB2蛋白封闭多肽 |
| 胞膜间内质网调节蛋白1封闭多肽 | ZNF71 Antibody Blocking Peptide |
| 芳香酯酶1(酶)封闭多肽 | PAA2 Antibody Blocking Peptide |
| 凋亡相关蛋白2封闭多肽 | DCP1A Antibody Blocking Peptide |
| 细胞表面趋化因子受体4相关蛋白6封闭多肽 | SHB Antibody Blocking Peptide |
| 线粒体rRNA甲基转移酶1封闭多肽 | GM-CSF Antibody Blocking Peptide |
| G蛋白偶联受体73B封闭多肽 | MAL2 Antibody Blocking Peptide |
| G蛋白γ11/Gγ11 封闭多肽 | 甘氨酰胺核苷酸合成酶封闭多肽 |
| 锌指蛋白71封闭多肽 | GNG11 Antibody Blocking Peptide |
| 妊娠相关血浆蛋白A2封闭多肽 | GPR73B Antibody Blocking Peptide |
| 含SH2结构域接头蛋白B封闭多肽 | MRM1 Antibody Blocking Peptide |
| 脱帽酶1A封闭多肽 | CNOT6 Antibody Blocking Peptide |
| 粒细胞-巨噬细胞克隆刺激因子封闭多肽 | ThalidomidePDCD2 Antibody Blocking Peptide |
| T淋巴细胞分化蛋白MAL2封闭多肽 | PON1 Antibody Blocking Peptide |
| LDB2 Antibody Blocking Peptide | RINT1 Antibody Blocking Peptide |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The Thalidomide Disaster, Lessons from the Past
It is close to 60 years since thalidomide was created by the German company, Chemie-Gr�nenthal, and launched as “Contergan.” This was soon to be followed in England by the launch of “Distaval.” Of all the drugs developed in the intervening
哺乳类缺少四肢或部分肢脚的一种畸形。完全缺乏者亦称为无肢畸形(amelia)。自然发生者相当罕见。酞胺哌啶酮( thalidomide)具有明显的引起这种畸形的作用。
In Vivo Animal Models of Teratogenicity
Before the advent of the thalidomide tragedy, it had often been assumed that the maternal biosystems of hepatic detoxification and metabolism, together with the placental barrier, acted as a shield and were a natural protection for the embryo
技术资料暂无技术资料 索取技术资料









